These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25747986)

  • 1. Efficient delivery to human lung fibroblasts (WI-38) of pirfenidone incorporated into liposomes modified with truncated basic fibroblast growth factor and its inhibitory effect on collagen synthesis in idiopathic pulmonary fibrosis.
    Togami K; Miyao A; Miyakoshi K; Kanehira Y; Tada H; Chono S
    Biol Pharm Bull; 2015; 38(2):270-6. PubMed ID: 25747986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible involvement of pirfenidone metabolites in the antifibrotic action of a therapy for idiopathic pulmonary fibrosis.
    Togami K; Kanehira Y; Tada H
    Biol Pharm Bull; 2013; 36(10):1525-7. PubMed ID: 24088250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of RGS2: a new mechanism for pirfenidone amelioration of pulmonary fibrosis.
    Xie Y; Jiang H; Zhang Q; Mehrotra S; Abel PW; Toews ML; Wolff DW; Rennard S; Panettieri RA; Casale TB; Tu Y
    Respir Res; 2016 Aug; 17(1):103. PubMed ID: 27549302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pirfenidone attenuates lung fibrotic fibroblast responses to transforming growth factor-β1.
    Jin J; Togo S; Kadoya K; Tulafu M; Namba Y; Iwai M; Watanabe J; Nagahama K; Okabe T; Hidayat M; Kodama Y; Kitamura H; Ogura T; Kitamura N; Ikeo K; Sasaki S; Tominaga S; Takahashi K
    Respir Res; 2019 Jun; 20(1):119. PubMed ID: 31185973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pirfenidone inhibits the expression of HSP47 in TGF-beta1-stimulated human lung fibroblasts.
    Nakayama S; Mukae H; Sakamoto N; Kakugawa T; Yoshioka S; Soda H; Oku H; Urata Y; Kondo T; Kubota H; Nagata K; Kohno S
    Life Sci; 2008 Jan; 82(3-4):210-7. PubMed ID: 18093617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pirfenidone on proliferation, migration, and collagen contraction of human Tenon's fibroblasts in vitro.
    Lin X; Yu M; Wu K; Yuan H; Zhong H
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3763-70. PubMed ID: 19264889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pirfenidone inhibits TGF-β1-induced over-expression of collagen type I and heat shock protein 47 in A549 cells.
    Hisatomi K; Mukae H; Sakamoto N; Ishimatsu Y; Kakugawa T; Hara S; Fujita H; Nakamichi S; Oku H; Urata Y; Kubota H; Nagata K; Kohno S
    BMC Pulm Med; 2012 Jun; 12():24. PubMed ID: 22694981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic administration of inhaled INS1009, a treprostinil prodrug formulation, inhibits bleomycin-induced pulmonary fibrosis in rats.
    Corboz MR; Zhang J; LaSala D; DiPetrillo K; Li Z; Malinin V; Brower J; Kuehl PJ; Barrett TE; Perkins WR; Chapman RW
    Pulm Pharmacol Ther; 2018 Apr; 49():95-103. PubMed ID: 29408757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-γ enhances the antifibrotic effects of pirfenidone by attenuating IPF lung fibroblast activation and differentiation.
    Vu TN; Chen X; Foda HD; Smaldone GC; Hasaneen NA
    Respir Res; 2019 Sep; 20(1):206. PubMed ID: 31511015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of TGF-β pathway by pirfenidone decreases extracellular matrix deposition in ocular fibroblasts in vitro.
    Stahnke T; Kowtharapu BS; Stachs O; Schmitz KP; Wurm J; Wree A; Guthoff RF; Hovakimyan M
    PLoS One; 2017; 12(2):e0172592. PubMed ID: 28231275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pirfenidone suppresses keloid fibroblast-embedded collagen gel contraction.
    Saito M; Yamazaki M; Maeda T; Matsumura H; Setoguchi Y; Tsuboi R
    Arch Dermatol Res; 2012 Apr; 304(3):217-22. PubMed ID: 22033529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-fibrotic effect of pirfenidone in muscle derived-fibroblasts from Duchenne muscular dystrophy patients.
    Zanotti S; Bragato C; Zucchella A; Maggi L; Mantegazza R; Morandi L; Mora M
    Life Sci; 2016 Jan; 145():127-36. PubMed ID: 26679108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifibrotic effects of a novel pirfenidone derivative in vitro and in vivo.
    Ma Z; Zhao C; Chen Q; Yu C; Zhang H; Zhang Z; Huang W; Shen Z
    Pulm Pharmacol Ther; 2018 Dec; 53():100-106. PubMed ID: 30394340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pirfenidone exerts antifibrotic effects through inhibition of GLI transcription factors.
    Didiasova M; Singh R; Wilhelm J; Kwapiszewska G; Wujak L; Zakrzewicz D; Schaefer L; Markart P; Seeger W; Lauth M; Wygrecka M
    FASEB J; 2017 May; 31(5):1916-1928. PubMed ID: 28148565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.
    Oku H; Shimizu T; Kawabata T; Nagira M; Hikita I; Ueyama A; Matsushima S; Torii M; Arimura A
    Eur J Pharmacol; 2008 Aug; 590(1-3):400-8. PubMed ID: 18598692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pirfenidone and nintedanib modulate properties of fibroblasts and myofibroblasts in idiopathic pulmonary fibrosis.
    Lehtonen ST; Veijola A; Karvonen H; Lappi-Blanco E; Sormunen R; Korpela S; Zagai U; Sköld MC; Kaarteenaho R
    Respir Res; 2016 Feb; 17():14. PubMed ID: 26846335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifibrotic effect of Pirfenidone on orbital fibroblasts of patients with thyroid-associated ophthalmopathy by decreasing TIMP-1 and collagen levels.
    Kim H; Choi YH; Park SJ; Lee SY; Kim SJ; Jou I; Kook KH
    Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3061-6. PubMed ID: 20053983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-fibrotic effects of pirfenidone and rapamycin in primary IPF fibroblasts and human alveolar epithelial cells.
    Molina-Molina M; Machahua-Huamani C; Vicens-Zygmunt V; Llatjós R; Escobar I; Sala-Llinas E; Luburich-Hernaiz P; Dorca J; Montes-Worboys A
    BMC Pulm Med; 2018 Apr; 18(1):63. PubMed ID: 29703175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pirfenidone Inhibits Cell Proliferation and Collagen I Production of Primary Human Intestinal Fibroblasts.
    Cui Y; Zhang M; Leng C; Blokzijl T; Jansen BH; Dijkstra G; Faber KN
    Cells; 2020 Mar; 9(3):. PubMed ID: 32235767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Antifibrotic Mechanism of Nintedanib and Pirfenidone. Inhibition of Collagen Fibril Assembly.
    Knüppel L; Ishikawa Y; Aichler M; Heinzelmann K; Hatz R; Behr J; Walch A; Bächinger HP; Eickelberg O; Staab-Weijnitz CA
    Am J Respir Cell Mol Biol; 2017 Jul; 57(1):77-90. PubMed ID: 28257580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.